Advertisement

Fall 32: Spätschäden – 48 Jahre, ♀, DM Typ 1, Insulinresistenz, Anstieg des Body-Mass-Index

  • Stefan Kopf
Chapter

Zusammenfassung

Eine 48-jährige Typ-1-Diabetikerin mit einem um 8 % eingestelltem HbA1c-Wert, einem LDL von 135 mg/dl hat jetzt seit Entwicklung einer Albuminurie eine Insulinresistenz bei einem Anstieg des Body-Mass-Index von ursprünglich 23 auf 33. Hat sie jetzt Typ-2-Diabetes und ändert dies etwas an ihrer Therapie?

Literatur

  1. Cleland SJ et al (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia 56(7):1462–1470CrossRefGoogle Scholar
  2. Erbey JR et al (1998) The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 21(4):610–614CrossRefGoogle Scholar
  3. Ku E et al (2016) Association between blood pressure and adverse renal events in type 1 diabetes. Diabetes Care 39(12):2218–2224CrossRefGoogle Scholar
  4. Lewis EJ et al (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. the collaborative study group. N Engl J Med 329(20):1456–1462CrossRefGoogle Scholar
  5. Purnell JQ et al (1998) Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 280(2):140–146PubMedGoogle Scholar
  6. Purnell JQ et al (2003) Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 52(10):2623–2629CrossRefGoogle Scholar
  7. Ray KK et al (2017) Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 170(12):1024–1031CrossRefGoogle Scholar
  8. Roglic G et al (1998) Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 15(5):418–426CrossRefGoogle Scholar
  9. Thorn LM et al (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32(5):950–952CrossRefGoogle Scholar
  10. Yip J et al (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342(8876):883–887CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Abteilung Innere Medizin IMedizinische UniversitätsklinikHeidelbergDeutschland

Personalised recommendations